Adempas: payments to doctors
Payments that named Adempas as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.7M
- Providers
- 7,906
- Transactions
- 29,793
- Average per transaction
- $193
The per-transaction average — $193 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,906 providers the average total is $726, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bayer | $5,727,353 | 99.8% |
| Merck | $9,112 | 0.2% |
| Bayer Puerto Rico Inc. | $309 | 0.0% |